Our commitment: Every client receives individualized assessment, customized dosing, and the highest quality care
1f,g) via the incretin receptors, and equally potentiated glucose-stimulated insulin secretion in isolated mouse islets (Fig
The FDA has approved Wegovy (semaglutide) and Zepbound (tirzepatide) specifically for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
Theres no denying that this drug class can lead to significant health benefits, particularly for those with type 2 diabetes and/or obesity
Fighting chronic oxidative stress So we know that endogenous antioxidants, such as glutathione, are great at mopping up free radicals on a one to one basis, and that enzymes such as the SOD or glutathione peroxidase (GPX) enzyme families can rapidly reduce oxidative stress
Primers 6 , 48 (2020)